WELLS FARGO & COMPANY/MN - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 40 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$1,299,033
+5.1%
557,525
+7.3%
0.00%
Q2 2023$1,236,272
+37.9%
519,442
+6.6%
0.00%
Q1 2023$896,759
+25.6%
487,369
+29.7%
0.00%
Q4 2022$713,756
-14.4%
375,661
-3.6%
0.00%
Q3 2022$834,000
-19.0%
389,839
+7.1%
0.00%
Q2 2022$1,030,000
+3.0%
363,955
+51.9%
0.00%
Q1 2022$1,000,000
-3.2%
239,635
+20.3%
0.00%
Q4 2021$1,033,000
-37.8%
199,173
-21.4%
0.00%
Q3 2021$1,660,000
+74.7%
253,430
+77.2%
0.00%
Q2 2021$950,000
+136.9%
143,004
+103.9%
0.00%
Q1 2021$401,000
+67.8%
70,136
+161.9%
0.00%
Q4 2020$239,000
+25.1%
26,775
+62.4%
0.00%
Q3 2020$191,000
-4.5%
16,483
+32.1%
0.00%
Q2 2020$200,000
+124.7%
12,476
-16.4%
0.00%
Q1 2020$89,000
+270.8%
14,921
+728.0%
0.00%
Q4 2019$24,000
-11.1%
1,802
-18.2%
0.00%
Q3 2019$27,000
+145.5%
2,202
+214.6%
0.00%
Q2 2019$11,000
+22.2%
700
+133.3%
0.00%
Q1 2019$9,000
-50.0%
300
-45.5%
0.00%
Q4 2018$18,000
-48.6%
550
-52.2%
0.00%
Q3 2018$35,000
+400.0%
1,150
+360.0%
0.00%
Q2 2018$7,0002500.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2018
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 21,346,829$49,738,11274.10%
TFG Asset Management GP Ltd 12,000,000$27,960,0005.10%
Paradigm Biocapital Advisors LP 14,406,782$33,567,8022.28%
Lynx1 Capital Management LP 1,363,025$3,175,8482.10%
Deep Track Capital, LP 15,000,000$34,950,0001.35%
Affinity Asset Advisors, LLC 1,992,466$4,642,4461.31%
DAFNA Capital Management LLC 928,253$2,162,8290.67%
Frazier Life Sciences Management, L.P. 3,746,857$8,730,1770.58%
ARMISTICE CAPITAL, LLC 6,900,000$16,077,0000.25%
Blackstone Inc. 20,485,611$47,731,4740.20%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders